{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:00:22Z","timestamp":1773842422170,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,29]]},"DOI":"10.7759\/cureus.49647","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T14:43:31Z","timestamp":1701269011000},"source":"Crossref","is-referenced-by-count":5,"title":["Epidemiological Trends and Factors Associated With Mortality Rate in Psychoactive Substance Use-Related Mental and Behavioral Disorders: A CDC-WONDER Database Analysis"],"prefix":"10.7759","author":[{"given":"Okelue E","family":"Okobi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngozi T","family":"Akueme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amogechukwu  O","family":"Ugwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imoh L","family":"Ebong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nnena","family":"Osagwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Opiegbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim L","family":"Folorunsho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda A","family":"Mbah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel I","family":"Ude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Leszkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000271","article-title":"Substance use disorders in global mental health delivery: epidemiology, treatment gap, and implementation of evidence-based treatments","volume":"28","author":"Connery HS","year":"2020","unstructured":"Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance use disorders in global mental health delivery: epidemiology, treatment gap, and implementation of evidence-based treatments. Harv Rev Psychiatry. 2020, 28:316-27. 10.1097\/HRP.0000000000000271","journal-title":"Harv Rev Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-021-01182-4","article-title":"Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment","volume":"17","author":"Crable EL","year":"2022","unstructured":"Crable EL, Benintendi A, Jones DK, Walley AY, Hicks JM, Drainoni ML. Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment. Implement Sci. 2022, 17:3. 10.1186\/s13012-021-01182-4","journal-title":"Implement Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/19371918.2013.774673","article-title":"Integrated treatment of substance use and psychiatric disorders","volume":"28","author":"Kelly TM","year":"2013","unstructured":"Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health. 2013, 28:388-406. 10.1080\/19371918.2013.774673","journal-title":"Soc Work Public Health"},{"key":"ref4","unstructured":"National Center for Drug Abuse Statistics. 2020. Drug abuse statistics. (2020). Accessed. June 12, 2023: https:\/\/drugabusestatistics.org\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_490_22","article-title":"Clinical practice guidelines for assessment and management of patients with substance intoxication presenting to the emergency department","volume":"65","author":"Sarkar S","year":"2023","unstructured":"Sarkar S, Bhatia G, Dhawan A. Clinical practice guidelines for assessment and management of patients with substance intoxication presenting to the emergency department. Indian J Psychiatry. 2023, 65:196-211. 10.4103\/indianjpsychiatry.indianjpsychiatry_490_22","journal-title":"Indian J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221139616","article-title":"Synthetic opioids: a review and clinical update","volume":"12","author":"Shafi A","year":"2022","unstructured":"Shafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. Synthetic opioids: a review and clinical update. Ther Adv Psychopharmacol. 2022, 12:20451253221139616. 10.1177\/20451253221139616","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001234","article-title":"Substance use and the nervous system","volume":"29","author":"Stitt D","year":"2023","unstructured":"Stitt D. Substance use and the nervous system. Continuum (Minneap Minn). 2023, 29:923-45. 10.1212\/CON.0000000000001234","journal-title":"Continuum (Minneap Minn)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2013.09.038","article-title":"Family and social aspects of substance use disorders and treatment","volume":"21","author":"Daley DC","year":"2013","unstructured":"Daley DC. Family and social aspects of substance use disorders and treatment. J Food Drug Anal. 2013, 21:S73-6. 10.1016\/j.jfda.2013.09.038","journal-title":"J Food Drug Anal"},{"key":"ref9","unstructured":"Centers for Disease Control and Prevention. (2023). Accessed. July 10, 2023: https:\/\/wonder.cdc.gov\/Deaths-by-Underlying-Cause.html."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226732","article-title":"Estimating the impact of drug use on US mortality, 1999-2016","volume":"15","author":"Glei DA","year":"2020","unstructured":"Glei DA, Preston SH. Estimating the impact of drug use on US mortality, 1999-2016. PLoS One. 2020, 15:e0226732. 10.1371\/journal.pone.0226732","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-04437-6","article-title":"Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety?","volume":"22","author":"Svensson J","year":"2022","unstructured":"Svensson J, Bergstr\u00f6m J, K\u00e5berg M, Becker P. Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety?. BMC Psychiatry. 2022, 22:770. 10.1186\/s12888-022-04437-6","journal-title":"BMC Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy288","article-title":"The contribution of drug-related deaths to the US disadvantage in mortality","volume":"48","author":"Barbieri M","year":"2019","unstructured":"Barbieri M. The contribution of drug-related deaths to the US disadvantage in mortality. Int J Epidemiol. 2019, 48:945-53. 10.1093\/ije\/dyy288","journal-title":"Int J Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003310","article-title":"Substance use disorder in physicians after completion of training in anesthesiology in the United States from 1977 to 2013","volume":"133","author":"Warner DO","year":"2020","unstructured":"Warner DO, Berge K, Sun H, Harman A, Wang T. Substance use disorder in physicians after completion of training in anesthesiology in the United States from 1977 to 2013. Anesthesiology. 2020, 133:342-9. 10.1097\/ALN.0000000000003310","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6619a1","article-title":"Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas - United States","volume":"66","author":"Mack KA","year":"2017","unstructured":"Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas - United States. MMWR Surveill Summ. 2017, 66:1-12. 10.15585\/mmwr.ss6619a1","journal-title":"MMWR Surveill Summ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13524-017-0565-3","article-title":"The contribution of drug overdose to educational gradients in life expectancy in the United States, 1992-2011","volume":"54","author":"Ho JY","year":"2017","unstructured":"Ho JY. The contribution of drug overdose to educational gradients in life expectancy in the United States, 1992-2011. Demography. 2017, 54:1175-202. 10.1007\/s13524-017-0565-3","journal-title":"Demography"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2023.02.016","article-title":"Trends in psychotropic drug-implicated cardiovascular mortality: patterns in U.S. mortality, 1999-2020","volume":"65","author":"Kelly BC","year":"2023","unstructured":"Kelly BC, Vuolo M. Trends in psychotropic drug-implicated cardiovascular mortality: patterns in U.S. mortality, 1999-2020. Am J Prev Med. 2023, 65:377-84. 10.1016\/j.amepre.2023.02.016","journal-title":"Am J Prev Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282056","article-title":"Trends of repeated emergency department visits among adolescents and young adults for substance use: a repeated cross-sectional study","volume":"18","author":"Kim S","year":"2023","unstructured":"Kim S, Weekes J, Young MM, Adams N, Kolla NJ. Trends of repeated emergency department visits among adolescents and young adults for substance use: a repeated cross-sectional study. PLoS One. 2023, 18:e0282056. 10.1371\/journal.pone.0282056","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/208777-epidemiological-trends-and-factors-associated-with-mortality-rate-in-psychoactive-substance-use-related-mental-and-behavioral-disorders-a-cdc-wonder-database-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:09Z","timestamp":1707509229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/208777-epidemiological-trends-and-factors-associated-with-mortality-rate-in-psychoactive-substance-use-related-mental-and-behavioral-disorders-a-cdc-wonder-database-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.49647","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}